Navigation Links
Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences
Date:6/8/2009

CINCINNATI, June 8 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Jefferies 3rd Annual Healthcare Conference on June 18 as well as the Wachovia Securities 19th Annual Mid-Year Equity Conference on June 24.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )

President Simon Higginbotham will participate in the June 18 Jefferies Conference. Chairman and Chief Executive Officer Candace Kendle, PharmD, and Senior Vice President and Chief Financial Officer Keith Cheesman will participate in the June 24 Wachovia Conference.

Jefferies 3rd Annual Healthcare Conference

The Jefferies 3rd Annual Healthcare Conference will be held June 17-18 at the Mandarin Oriental Hotel in New York City. The Kendle presentation by Mr. Higginbotham is scheduled for Thursday, June 18 at 10:45 a.m. Eastern Time.

The presentation will be Webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/jeff35/kndl/. Slides will be available by 8 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

Wachovia Securities 19th Annual Mid-Year Equity Conference

The Wachovia Securities 19th Annual Mid-Year Equity Conference will be held June 23-24 at the Intercontinental Boston Hotel in Boston. The Kendle presentation by Dr. Kendle and Mr. Cheesman is scheduled for Wednesday, June 24 at 3 p.m. Eastern Time.

The presentation will be Webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/wa55/kndl. Slides will be available by 8 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
2. Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India
3. Kendle Revises Full Year 2008 Guidance
4. Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
5. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
6. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
7. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
8. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
9. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
10. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
11. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... industry, ranked among the top five firms in the “2015/2016 Best in KLAS: ... Support and Staffing. KLAS is a research and insights firm on a global ...
(Date:2/11/2016)... ... 2016 , ... In a new paper published in the ... Rod J. Rohrich, and colleagues, examine and underscore the importance of upper lateral ... when addressing this vital area. , The upper lateral cartilage in rhinoplasty, refers ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back from ... poses a question as a challenge for his readers to examine the full ... Being" (published by Partridge Singapore), Clarke explores the subject with more depth, revealing ...
(Date:2/11/2016)... ... February 11, 2016 , ... Colorado spine surgeon, Donald Corenman, ... 334 spine surgeons to know in 2016 . The list consists of spine surgeons ... surgery. , Dr. Corenman understands the importance of clinical excellence; he has been ...
(Date:2/11/2016)... ... 2016 , ... Dickinson Insurance & Financial Services continues their commitment to act ... of a local boy named Barrett, who has been fighting ALL leukemia for almost ... support for, all local families dealing with childhood cancer. Information on how to help ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)...  Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare ... conditions, announced today that the Company will present its ... on Tuesday, February 16, 2016, at 4:30 p.m. ET.  ... overview of its business and growth strategy, as well ... 31, 2015. --> ...
(Date:2/11/2016)...  Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced today, ... Controlled Equity Offering SM Sales Agreement with Cantor ... , Chairman and CEO, stated "During our most recent ... raising money and that we have enough money to ... complete all of our current objectives and nothing has ...
(Date:2/11/2016)... 2016 North America , ... MarketsandMarkets, The global market is expected to reach USD 20,190.1 Million ... CAGR of 10.2%. --> North America , ... by MarketsandMarkets, The global market is expected to reach USD 20,190.1 ... a CAGR of 10.2%. --> According to a new ...
Breaking Medicine Technology: